| |
| |
|
| Insider
Information: |
Sonsini Peter W. |
| Relationship: |
10% Owner |
| City: |
Menlo Park |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
39 |
|
| Direct
Shares |
66,219,175 |
|
|
Indirect Shares
|
287,129,918 |
|
|
| Direct
Value |
$484,917,870 |
|
|
|
Indirect Value
|
$554,586,967 |
|
|
| Total
Shares |
353,349,093 |
|
|
| Total
Value |
$1,039,504,837 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
5
|
0
|
|
Stock
price went up :
|
2
|
0
|
| Stock
price went down : |
3
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
 21.6%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Interleukin Genetics Inc |
ILIU |
10% Owner |
|
0 |
2016-07-29 |
55,418,811 |
Premium* |
|
|
Loxo Oncology, Inc. |
LOXO |
10% Owner |
2014-08-06 |
0 |
2014-08-06 |
1,789,420 |
Premium* |
|
|
Tracon Pharmaceuticals, Inc. |
TCON |
10% Owner |
2015-02-04 |
0 |
2016-11-29 |
2,758,039 |
Premium* |
|
|
Champions Biotechnology Inc |
CSBR |
10% Owner |
|
0 |
2015-03-11 |
18,750,000 |
Premium* |
|
|
Ardelyx Inc |
ARDX |
10% Owner |
|
0 |
2019-12-09 |
6,564,372 |
Premium* |
|
|
Nuvelo Inc |
ABIO |
10% Owner |
|
0 |
2018-02-26 |
0 |
Premium* |
|
|
Synlogic Inc |
SYBX |
10% Owner |
2015-10-05 |
0 |
2018-01-26 |
4,228,940 |
Premium* |
|
|
Avalo Therapeutics, Inc |
AVTX |
10% Owner |
2015-10-20 |
0 |
2015-10-20 |
594,245 |
Premium* |
|
|
Adaptimmune Therapeutics PLC |
ADAP |
10% Owner |
|
0 |
2020-01-24 |
102,478,668 |
Premium* |
|
|
Aveo Pharmaceuticals Inc |
AVEO |
10% Owner |
|
0 |
2022-10-19 |
24 |
Premium* |
|
|
Achaogen Inc |
AKAO |
10% Owner |
|
0 |
2016-12-19 |
5,215,128 |
Premium* |
|
|
Cascadian Therapeutics, Inc |
CASC |
10% Owner |
|
0 |
2018-03-09 |
0 |
Premium* |
|
|
Mulesoft, Inc |
MULE |
10% Owner |
|
0 |
2018-05-01 |
0 |
Premium* |
|
|
Mersana Therapeutics, Inc. |
MRSN |
10% Owner |
2020-09-14 |
745 |
2020-09-14 |
596 |
Premium* |
|
|
Regulus Therapeutics Inc. |
RGLS |
10% Owner |
|
0 |
2020-12-04 |
6,451,056 |
Premium* |
|
|
Surface Oncology, Inc. |
SURF |
10% Owner |
2020-05-20 |
2,892,877 |
2018-04-23 |
3,312,877 |
Premium* |
|
|
Appian Corp |
APPN |
10% Owner |
2018-02-13 |
339 |
2018-02-13 |
676 |
Premium* |
|
|
Genocea Biosciences, Inc. |
GNCA |
10% Owner |
2019-02-14 |
0 |
2022-05-25 |
0 |
Premium* |
|
|
Trevi Therapeutics, Inc. |
TRVI |
10% Owner |
2019-05-09 |
0 |
2022-04-11 |
948,948 |
Premium* |
|
|
Mirum Pharmaceuticals, Inc. |
MIRM |
10% Owner |
2019-07-22 |
0 |
2019-07-22 |
4,186,243 |
Premium* |
|
|
Akouos, Inc. |
AKUS |
10% Owner |
2020-06-30 |
0 |
2022-11-30 |
0 |
Premium* |
|
|
Nkarta, Inc. |
NKTX |
10% Owner |
2020-07-14 |
0 |
2020-07-14 |
2,902,115 |
Premium* |
|
|
Inozyme Pharma, Inc. |
INZY |
10% Owner |
2020-07-28 |
0 |
2020-07-28 |
2,437,689 |
Premium* |
|
|
Metacrine, Inc. |
MTCR |
10% Owner |
2020-09-18 |
0 |
2021-12-22 |
2,563,257 |
Premium* |
|
|
Eargo, Inc. |
EAR |
10% Owner |
2020-10-20 |
0 |
2021-05-24 |
821 |
Premium* |
|
|
Desktop Metal Ord Shs Class A |
DM |
10% Owner |
|
0 |
2021-06-08 |
54 |
Premium* |
|
|
Savara Inc |
SVRA |
10% Owner |
|
0 |
2021-03-15 |
24,137,931 |
Premium* |
|
|
Marker Therapeutics Inc |
MRKR |
10% Owner |
2021-03-16 |
0 |
2021-03-16 |
10,714,285 |
Premium* |
|
|
Reneo Pharmaceuticals, Inc. |
RPHM |
10% Owner |
2021-04-13 |
4,785,494 |
2021-04-13 |
0 |
Premium* |
|
|
Bright Health Group Inc. |
BHG |
10% Owner |
|
0 |
2021-06-28 |
23,983,073 |
Premium* |
|
|
Monte Rosa Therapeutics, Inc. |
GLUE |
10% Owner |
2021-06-28 |
0 |
2021-06-28 |
7,692,298 |
Premium* |
|
|
Robinhood Markets, Inc. |
HOOD |
Director |
2021-08-02 |
0 |
2022-05-02 |
270 |
Premium* |
|
|
Ionq Ord Shs |
IONQ |
10% Owner |
2022-05-31 |
26,306,693 |
2022-11-16 |
70 |
Premium* |
|
|
Enliven Therapeutics Ord Shs |
ELVN |
10% Owner |
2022-01-25 |
3,305,601 |
2021-12-27 |
0 |
Premium* |
|
|
Casper Sleep Inc. |
CSPR |
10% Owner |
2022-01-25 |
0 |
2022-01-25 |
0 |
Premium* |
|
|
Arcellx, Inc. |
ACLX |
10% Owner |
2022-02-08 |
6,432,762 |
2022-12-20 |
12 |
Premium* |
|
|
Senti Biosciences, Inc |
SNTI |
10% Owner |
2022-06-08 |
4,426,151 |
|
0 |
Premium* |
|
|
Zerofox Holdings Ord Shs |
ZFOX |
10% Owner |
2022-08-03 |
18,068,513 |
|
0 |
Premium* |
|
|
Oyster Point Pharma, Inc. |
OYST |
10% Owner |
2023-01-03 |
0 |
2023-01-03 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
176 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 7 of 8
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AKAO |
Achaogen Inc |
10% Owner |
– – • |
2016-12-19 |
4 |
B |
$13.50 |
$6,750,000 |
I/I |
500,000 |
5,215,128 |
1.5 |
- |
|
| MIRM |
Mirum Pharmaceuticals, In... |
10% Owner |
– – • |
2019-07-22 |
4 |
B |
$15.00 |
$6,750,000 |
I/I |
450,000 |
4,186,243 |
1.5 |
- |
|
| TRVI |
Trevi Therapeutics, Inc. |
10% Owner |
– – • |
2022-04-11 |
4 |
B |
$1.90 |
$6,802,999 |
I/I |
3,580,526 |
948,948 |
1.5 |
- |
|
| GNCA |
Genocea Biosciences, Inc. |
10% Owner |
– – • |
2020-07-24 |
4 |
B |
$2.25 |
$7,090,335 |
I/I |
3,151,260 |
10,376,936 |
1.5 |
- |
|
| AVEO |
Aveo Pharmaceuticals Inc |
10% Owner |
– – • |
2020-06-19 |
4 |
B |
$5.25 |
$7,499,998 |
I/I |
1,428,571 |
3,952,958 |
1.5 |
% |
|
| IONQ |
Ionq Ord Shs |
10% Owner |
– – • |
2022-05-27 |
4 |
S |
$5.93 |
$8,880,359 |
D/D |
(1,497,733) |
26,805,307 |
0 |
- |
|
| ADAP |
Adaptimmune Therapeutics ... |
10% Owner |
– – • |
2017-03-27 |
4 |
B |
$0.70 |
$9,009,000 |
I/I |
12,870,000 |
72,139,000 |
1.5 |
- |
|
| MTCR |
Metacrine, Inc. |
10% Owner |
– – • |
2020-09-18 |
4 |
B |
$13.00 |
$9,999,990 |
I/I |
769,230 |
3,060,527 |
1.5 |
- |
|
| RPHM |
Reneo Pharmaceuticals, In... |
10% Owner |
– – • |
2021-04-13 |
4 |
B |
$15.00 |
$9,999,990 |
D/D |
666,666 |
4,785,494 |
2.45 |
% |
|
| AKUS |
Akouos, Inc. |
10% Owner |
– – • |
2020-06-30 |
4 |
B |
$17.00 |
$9,999,995 |
I/I |
588,235 |
4,294,207 |
1.5 |
- |
|
| GNCA |
Genocea Biosciences, Inc. |
10% Owner |
– – • |
2019-06-24 |
4 |
B |
$3.50 |
$9,999,997 |
I/I |
2,857,142 |
7,225,676 |
1.5 |
- |
|
| MRKR |
Marker Therapeutics Inc |
10% Owner |
– – • |
2021-03-16 |
4 |
B |
$1.75 |
$9,999,999 |
I/I |
5,714,285 |
10,714,285 |
1.5 |
- |
|
| ARDX |
Ardelyx Inc |
10% Owner |
– – • |
2016-01-13 |
4 |
B |
$10.00 |
$10,000,000 |
I/I |
1,000,000 |
1,901,869 |
1.5 |
- |
|
| APPN |
Appian Corp |
10% Owner |
– – • |
2017-11-27 |
4 |
S |
$19.49 |
$11,101,894 |
I/I |
(569,620) |
0 |
0 |
- |
|
| ADAP |
Adaptimmune Therapeutics ... |
10% Owner |
– – • |
2018-03-27 |
4 |
B |
$1.92 |
$11,500,200 |
I/I |
6,000,000 |
79,978,672 |
1.5 |
- |
|
| NKTX |
Nkarta, Inc. |
10% Owner |
– – • |
2020-07-14 |
4 |
B |
$18.00 |
$11,999,988 |
I/I |
666,666 |
2,902,115 |
1.5 |
- |
|
| ARDX |
Ardelyx Inc |
10% Owner |
– – • |
2016-07-18 |
4 |
B |
$8.73 |
$13,333,338 |
I/I |
1,527,301 |
2,665,519 |
1.5 |
- |
|
| MRSN |
Mersana Therapeutics, Inc... |
10% Owner |
– – • |
2017-07-03 |
4 |
B |
$15.00 |
$15,000,000 |
I/I |
1,000,000 |
8,140,138 |
1.5 |
- |
|
| GLUE |
Monte Rosa Therapeutics, ... |
10% Owner |
– – • |
2021-06-28 |
4 |
B |
$19.00 |
$19,950,000 |
I/I |
1,050,000 |
7,692,298 |
1.5 |
- |
|
| ACLX |
Arcellx, Inc. |
10% Owner |
– – • |
2022-02-08 |
4 |
B |
$15.00 |
$23,749,995 |
D/D |
1,583,333 |
6,432,762 |
2.45 |
- |
|
| TRVI |
Trevi Therapeutics, Inc. |
10% Owner |
– – • |
2019-05-09 |
4 |
B |
$10.00 |
$25,000,000 |
I/I |
2,500,000 |
4,438,562 |
1.5 |
- |
|
| ADAP |
Adaptimmune Therapeutics ... |
10% Owner |
– – • |
2018-09-07 |
4 |
B |
$1.67 |
$25,000,500 |
I/I |
15,000,000 |
12,000,000 |
1.5 |
- |
|
| BHG |
Bright Health Group Inc. |
10% Owner |
– – • |
2021-06-28 |
4 |
B |
$18.00 |
$34,999,992 |
I/I |
1,944,444 |
23,983,073 |
1.5 |
% |
|
| CSPR |
Casper Sleep Inc. |
10% Owner |
– – • |
2022-01-25 |
4 |
D |
$6.90 |
$42,935,264 |
D/D |
(6,222,502) |
0 |
0 |
- |
|
| APPN |
Appian Corp |
10% Owner |
– – • |
2017-11-20 |
4 |
S |
$19.49 |
$54,971,857 |
I/I |
(2,820,516) |
0 |
0 |
- |
|
176 Records found
|
|
Page 7 of 8 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
